ARTICLE | Clinical News
MatriStem MicroMatrix: Phase IV started
January 27, 2014 8:00 AM UTC
ACell began a single-blind, U.S. Phase IV trial to compare standard of care (SOC) plus MatriStem MicroMatrix particles or MatriStem Wound Matrix sheets vs. SOC plus Dermagraft in about 102 patients w...